ALLO - Allogene Therapeutics, Inc.
NEXT EARNINGS:
Mar 12, 2026
(in 15 days)
EPS Est: $-0.25
|
Rev Est: $2000
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$29.00
DETAILS
HIGH:
$55.00
LOW:
$7.00
MEDIAN:
$33.50
CONSENSUS:
$29.00
UPSIDE:
1166.38%
Market Cap:
514.63M
Volume:
6,616,727
Avg Volume:
4,551,060
52 Week Range:
0.86-2.32
Sector:
Healthcare
Industry:
Biotechnology
Beta:
0.60
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
226
IPO Date:
2018-10-11
EPS (TTM):
-1.32
P/E Ratio:
-1.61
Revenue (TTM):
22,000
Total Assets:
548.71M
Total Debt:
90.76M
Cash & Equiv:
75.22M
Rev Growth (5Y):
-94.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-50.1%
Debt/Equity:
0.21
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $-0.19 | $-0.23 | +17.4% | — | $1820 | — |
| 2025-08-13 | $-0.23 | $-0.28 | +17.9% | — | — | — |
| 2025-05-13 | $-0.28 | $-0.28 | 0.0% | — | $1670 | — |
| 2025-03-13 | $-0.28 | $-0.34 | +17.6% | $22000 | $12000 | +83.3% |
| 2024-11-07 | $-0.27 | $-0.34 | +20.6% | — | $12110 | — |
| 2024-08-07 | $-0.32 | $-0.35 | +8.6% | — | $20000 | — |
| 2024-05-13 | $-0.38 | $-0.38 | 0.0% | $22000 | $10000 | +120.0% |
| 2024-03-14 | $-0.43 | $-0.47 | +8.5% | $21000 | $20000 | +5.0% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22,000 | 95,000 | 156,000 | 114.09M | 0 | 0 | 0 | 0 |
| Net Income | (257.59M) | (327.26M) | (340.41M) | (182.05M) | (250.22M) | (184.59M) | (211.50M) | (2,000) |
| EPS | -1.32 | -2.09 | -2.38 | -1.34 | -2.08 | -1.83 | -2.36 | 0.00 |
| Total Assets | 548.71M | 642.84M | 821.58M | 1.05B | 1.23B | 717.80M | 773.86M | 0 |
| Total Debt | 90.76M | 95.12M | 101.12M | 73.13M | 53.78M | 53.03M | 34.46M | 0 |
| Cash & Equivalents | 75.22M | 83.16M | 61.90M | 173.31M | 183.35M | 175.13M | 721.35M | 0 |
| Operating Cash Flow | (200.30M) | (237.73M) | (220.52M) | (184.81M) | (115.09M) | (137.35M) | (44.65M) | 0 |
| Free Cash Flow | (200.99M) | (239.25M) | (225.71M) | (206.26M) | (181.05M) | (188.14M) | (47.89M) | 0 |
| FCF per Share | -1.03 | -1.52 | -1.58 | -1.52 | -1.50 | -1.86 | -0.53 | N/A |
| Book Value | 422.18M | 512.23M | 666.88M | 925.20M | 1.08B | 629.02M | 703.16M | (2,000) |
| Cash & ST Investments | 292.48M | 448.70M | 517.32M | 457.30M | 827.91M | 530.53M | 721.35M | 0 |
| ROC Equity | -0.61 | -0.64 | -0.51 | -0.20 | -0.23 | -0.29 | -0.30 | N/A |